XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash Flows From Operating Activities:    
Net income (loss) $ (707,460) $ (474,440)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization 223,273 277,562
Amortization of debt discount 18,037 21,120
Accretion of asset retirement obligation 1,537 1,537
Common stock issued for services 136,000 0
Common stock payable for directors fees 31,250 43,750
Foreign exchange (gain) loss 0 50,000
Other, net (598) (444)
Change in:    
Accounts receivable 103,205 (49,967)
Inventories (132,387) 273,615
Other current assets 0 4,697
IVA receivable and other assets (34,018) (45,609)
Accounts payable 119,082 16,202
Accrued payroll, taxes and interest 103,426 10,015
Other accrued liabilities 24,099 27,271
Deferred revenue 0 116
Payables to related party 28,964 8,236
Net cash provided (used) by operating activities (85,590) 163,661
Cash Flows From Investing Activities:    
Payment received on note receivable - sale of land 400,000 0
Purchase of properties, plants and equipment (312,568) (94,805)
Net cash provided (used) by investing activities 87,432 (94,805)
Cash Flows From Financing Activities:    
Change in checks issued and payable (845) (17,203)
Net borrowing from factor (11,084) 1,870
Advance from related party 125,200 75,000
Principal paid on notes payable to bank (70,792) (95,448)
Principal payments of net debt (57,467) (48,681)
Net cash provided (used) by financing activities (14,988) (84,462)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH (13,146) (15,606)
Cash and cash equivalents and restricted cash at beginning of period 113,897 91,332
Cash and cash equivalents and restricted cash at end of period $ 100,751 $ 75,726